Pioneering breakthrough in treatment of ‘devastating’ neurological disorder

IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease). IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning,...

AI could improve diagnosis for over 100,000 prostate patients in UK

The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK. Real-world data from hospitals and scanner types is being scrutinised, to show...

Advances in longitudinal RWD and genomics access for drug development in Africa

A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent. The collaboration is between BC Platforms (BCP), a global...

Novel mechanism links IBD genetic defect to gut leakiness

A study into ‘leaky gut’ is the first to show how a disease mutation increases the risk of developing Inflammatory Bowel Disease (IBD). Researchers led by a biomedical scientist at the University of California, Riverside,...

Antimicrobial resistance ‘arms race’ heats up

An advanced interventional microbiomics company, which is developing non-antibiotic methods for the control of multiple-drug resistant superbugs and other infectious disease, is stepping up development of a cure for antibiotic resistant bacteria. BioPlx has set...

Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations

Nemera is excited to announce that its multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug (NSAID) that is used...

Legal Cannabis Market in Europe Set to be Worth €3.2 billion by 2025

The European cannabis market is forecast to grow with a compound annual growth rate (CAGR) of 67.4% to reach €3.2 billion by 2025, a new report has found. The European Cannabis Report: 6th Edition, released...

Zotefoams hosts virtual opening of new £23million plant in Poland

Over 140 customers from 21 countries today attended the virtual opening of Zotefoams’ new state-of-the-art plant located in Brzeg in south-west Poland. In a key strategic move to increase global capacity and optimise service...

Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities

This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the...

Safe’n’Spray: Winner at CPhI Festival of Pharma

Nemera’s  concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October 2020 on the digital platform of CPhI Festival of Pharma. Safe’n’Spray is...

UCLB spinout Freeline Closes $120 Million Series C Financing Round

Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline of $40 million (£30.6 million) with an additional...

Arctoris and Syntekabio Form Research Partnership

Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of Understanding with listed Korean company Syntekabio, Inc. to collaborate on drug discovery efforts. The first project under...

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Next Generation ADC Uses Proprietary Technologies Aimed at Enhancing Cancer Therapy Efficacy and Safety Nijmegen, The Netherlands – 11 August 2020 – Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients...

UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S....

London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company,...

Nemera takes dermal treatments to millions of patients

Nemera is a world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, including complex dermal drug delivery devices. Dermal pharmaceuticals, cosmetics and personal hygiene products all...

Nemera and Noble announce collaboration to support patients who self-administer medication

 Nemera is excited to leverage the new collaboration to expand end-to-end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices  Nemera, world leader in design, development and manufacturing of drug...